10-K Filing

PFIZER INC CIK: 78003 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0000078003-22-000027`
Period End Date	20211231
Filing Date	20220224
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	pfe-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 69 Cash Flow Statement 155 Stockholders Equity 39 Comprehensive Income 63

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$508.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$492.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.00B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.79B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.94B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.64B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$29.12B	USD	Point-in-time
Short-term investments	`OtherShortTermInvestments`	$10.44B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	27.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	27.00M	shares	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$492; 2020$508	`AccountsReceivableNetCurrent`	$11.48B	USD	Point-in-time
Trade accounts receivable, less allowance for doubtful accounts: 2021$492; 2020$508	`AccountsReceivableNetCurrent`	$7.91B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$9.06B	USD	Point-in-time
Inventories	`InventoryNet`	$8.02B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$4.27B	USD	Point-in-time
Current tax assets	`OtherTaxAssetsCurrent`	$3.26B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.00B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.65B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.82B	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.00B	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	9.47B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$35.07B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$59.69B	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	9.41B	shares	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.47B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	3.85B	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	3.84B	shares	Point-in-time
Equity-method investments	`EquityMethodInvestments`	$16.86B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$5.05B	USD	Point-in-time
Long-term investments	`OtherLongTermInvestments`	$3.41B	USD	Point-in-time
Property, plant and equipment	`PropertyPlantAndEquipmentNet`	$14.88B	USD	Point-in-time
Property, plant and equipment	`PropertyPlantAndEquipmentNet`	$13.74B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$25.15B	USD	Point-in-time
Identifiable intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$28.34B	USD	Point-in-time
Goodwill	`Goodwill`	$49.21B	USD	Point-in-time
Goodwill	`Goodwill`	$49.56B	USD	Point-in-time
Goodwill	`Goodwill`	$48.18B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$2.38B	USD	Point-in-time
Noncurrent deferred tax assets and other noncurrent tax assets	`DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent`	$3.34B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$4.88B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$7.68B	USD	Point-in-time
Total assets	`Assets`	$181.48B	USD	Point-in-time
Total assets	`Assets`	$154.23B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$1,636; 2020$2,002	`DebtCurrent`	$2.70B	USD	Point-in-time
Short-term borrowings, including current portion of long-term debt: 2021$1,636; 2020$2,002	`DebtCurrent`	$2.24B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.28B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$5.58B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.16B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$2.25B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.27B	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$1.05B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.33B	USD	Point-in-time
Accrued compensation and related items	`EmployeeRelatedLiabilitiesCurrent`	$3.05B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$1.11B	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$3.07B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$11.56B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$24.94B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$25.92B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.67B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$36.20B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$37.13B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$3.49B	USD	Point-in-time
Pension benefit obligations	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$4.77B	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$235.00M	USD	Point-in-time
Postretirement benefit obligations	`OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent`	$645.00M	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$4.06B	USD	Point-in-time
Noncurrent deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$349.00M	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.33B	USD	Point-in-time
Other taxes payable	`LiabilityForUncertainTaxPositionsNoncurrent`	$11.56B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$6.67B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$9.74B	USD	Point-in-time
Total liabilities	`Liabilities`	$90.76B	USD	Point-in-time
Total liabilities	`Liabilities`	$104.01B	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value, at stated value; 27 shares authorized; no shares issued or outstanding at December 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value, at stated value; 27 shares authorized; no shares issued or outstanding at December 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.05 par value; 12,000 shares authorized; issued: 20219,471; 20209,407	`CommonStockValue`	$470.00M	USD	Point-in-time
Common stock, $0.05 par value; 12,000 shares authorized; issued: 20219,471; 20209,407	`CommonStockValue`	$473.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.67B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$90.59B	USD	Point-in-time
Treasury stock, shares at cost: 20213,851; 20203,840	`TreasuryStockValue`	$110.99B	USD	Point-in-time
Treasury stock, shares at cost: 20213,851; 20203,840	`TreasuryStockValue`	$111.36B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$90.39B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$103.39B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.90B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$63.24B	USD	Point-in-time
Total Pfizer Inc. shareholders equity	`StockholdersEquity`	$77.20B	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$262.00M	USD	Point-in-time
Equity attributable to noncontrolling interests	`MinorityInterest`	$235.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.76B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$181.48B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$154.23B	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.91B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$81.29B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$41.65B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$8.05B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$8.48B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$30.82B	USD	Annual
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$11.60B	USD	Annual
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$12.73B	USD	Annual
Selling, informational and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$12.70B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$8.38B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$13.83B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$9.39B	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$3.70B	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$4.43B	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction`	$3.35B	USD	Annual
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$579.00M	USD	Annual
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$802.00M	USD	Annual
Restructuring charges and certain acquisition-related costs	`RestructuringChargesAndAcquisitionRelatedCosts`	$601.00M	USD	Annual
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	-	USD	Annual
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	$8.11B	USD	Annual
(Gain) on completion of Consumer Healthcare JV transaction	`DeconsolidationGainOrLossAmount`	$6.00M	USD	Annual
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-1.22B	USD	Annual
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$-3.50B	USD	Annual
Other (income)/deductionsnet	`OtherNonoperatingIncomeExpense`	$4.88B	USD	Annual
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$24.31B	USD	Annual
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.04B	USD	Annual
Income from continuing operations before provision/(benefit) for taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$11.32B	USD	Annual
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$583.00M	USD	Annual
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$370.00M	USD	Annual
Provision/(benefit) for taxes on income	`IncomeTaxExpenseBenefit`	$1.85B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.67B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$10.74B	USD	Annual
Income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$22.46B	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.53B	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-434.00M	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$5.32B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$16.06B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$22.02B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$9.20B	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$36.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$29.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$45.00M	USD	Annual
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$16.03B	USD	Annual
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$21.98B	USD	Annual
Net income attributable to Pfizer Inc. common shareholders	`NetIncomeLoss`	$9.16B	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.00	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.92	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.19	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.08	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.46	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.95	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$2.88	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.65	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareBasic`	$3.92	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.18	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.89	USD	Annual
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$3.93	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.45	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.08	USD	Annual
Discontinued operationsnet of tax (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.94	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.63	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$3.85	USD	Annual
Net income attributable to Pfizer Inc. common shareholders (in dollars per share)	`EarningsPerShareDiluted`	$2.82	USD	Annual
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.57B	shares	Annual
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.60B	shares	Annual
Weighted-average sharesbasic	`WeightedAverageNumberOfSharesOutstandingBasic`	5.55B	shares	Annual
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.71B	shares	Annual
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.67B	shares	Annual
Weighted-average sharesdiluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.63B	shares	Annual

Cash Flow Statement 155 line items

Line Item	Tag	Value	Unit	Period
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$6.00M	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$16.06B	USD	Annual
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$8.25B	USD	Annual
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	-	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$22.02B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$9.20B	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$5.32B	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-434.00M	USD	Annual
Discontinued operationsnet of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.53B	USD	Annual
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$22.46B	USD	Annual
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.67B	USD	Annual
Net income from continuing operations before allocation to noncontrolling interests	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$10.74B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$5.19B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$4.68B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization`	$5.75B	USD	Annual
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$2.89B	USD	Annual
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$276.00M	USD	Annual
Asset write-offs and impairments	`AssetWriteOffsAndAssetImpairmentCharges`	$2.05B	USD	Annual
TCJA impact	`TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit`	-	USD	Annual
TCJA impact	`TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit`	-	USD	Annual
TCJA impact	`TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit`	$-323.00M	USD	Annual
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$6.00M	USD	Annual
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	$8.25B	USD	Annual
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed	`DeconsolidationGainLossAmountNetOfCashConveyed`	-	USD	Annual
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$561.00M	USD	Annual
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-4.29B	USD	Annual
Deferred taxes from continuing operations	`DeferredIncomeTaxExpenseBenefit`	$-1.57B	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$687.00M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$755.00M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$1.18B	USD	Annual
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$3.12B	USD	Annual
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$55.00M	USD	Annual
Benefit plan contributions in excess of expense/income	`PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense`	$1.24B	USD	Annual
Other adjustments, net	`OtherNoncashIncomeExpense`	$479.00M	USD	Annual
Other adjustments, net	`OtherNoncashIncomeExpense`	$1.57B	USD	Annual
Other adjustments, net	`OtherNoncashIncomeExpense`	$1.08B	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.27B	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.81B	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.12B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.12B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$1.07B	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$778.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-847.00M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.06B	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$137.00M	USD	Annual
Trade accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$355.00M	USD	Annual
Trade accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-341.00M	USD	Annual
Trade accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.24B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.77B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$18.72B	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$861.00M	USD	Annual
Other tax accounts, net	`IncreaseDecreaseInAccruedTaxesPayable`	$-3.07B	USD	Annual
Other tax accounts, net	`IncreaseDecreaseInAccruedTaxesPayable`	$-1.17B	USD	Annual
Other tax accounts, net	`IncreaseDecreaseInAccruedTaxesPayable`	$-1.24B	USD	Annual
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$32.92B	USD	Annual
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$10.54B	USD	Annual
Net cash provided by operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$7.01B	USD	Annual
Net cash provided by/(used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$5.57B	USD	Annual
Net cash provided by/(used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-343.00M	USD	Annual
Net cash provided by/(used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$3.86B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.59B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$14.40B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$32.58B	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.71B	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.05B	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.23B	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$6.83B	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$13.80B	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$38.46B	USD	Annual
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$9.18B	USD	Annual
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$27.45B	USD	Annual
Proceeds from redemptions/sales of short-term investments	`ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments`	$11.09B	USD	Annual
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$-920.00M	USD	Annual
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$8.09B	USD	Annual
Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less	`PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess`	$-6.92B	USD	Annual
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$597.00M	USD	Annual
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$201.00M	USD	Annual
Purchases of long-term investments	`PaymentsToAcquireMarketableSecurities`	$1.07B	USD	Annual
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$723.00M	USD	Annual
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$649.00M	USD	Annual
Proceeds from redemptions/sales of long-term investments	`ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments`	$232.00M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$10.86B	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$305.00M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$265.00M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$223.00M	USD	Annual
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.83B	USD	Annual
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-4.16B	USD	Annual
Net cash provided by/(used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-22.53B	USD	Annual
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-12.00M	USD	Annual
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-109.00M	USD	Annual
Net cash provided by/(used in) investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-120.00M	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.27B	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.55B	USD	Annual
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.94B	USD	Annual
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	-	USD	Annual
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$16.45B	USD	Annual
Proceeds from short-term borrowings	`ProceedsFromShortTermDebt`	$12.35B	USD	Annual
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$22.20B	USD	Annual
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	$8.38B	USD	Annual
Principal payments on short-term borrowings	`RepaymentsOfShortTermDebt`	-	USD	Annual
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-96.00M	USD	Annual
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$-4.13B	USD	Annual
Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less	`ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess`	$2.55B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.94B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$997.00M	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.22B	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$6.81B	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$4.00B	USD	Annual
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$2.00B	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$8.87B	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$8.44B	USD	Annual
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$8.04B	USD	Annual
Cash dividends paid	`PaymentsOfOrdinaryDividends`	$8.73B	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$16.00M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-342.00M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-444.00M	USD	Annual
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-21.64B	USD	Annual
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-9.82B	USD	Annual
Net cash provided by/(used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-8.48B	USD	Annual
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	$11.99B	USD	Annual
Net cash provided by/(used in) financing activities from discontinued operations	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.65B	USD	Annual
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.48B	USD	Annual
Net cash provided by/(used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.82B	USD	Annual
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-32.00M	USD	Annual
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-8.00M	USD	Annual
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-59.00M	USD	Annual
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$475.00M	USD	Annual
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$125.00M	USD	Annual
Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$159.00M	USD	Annual
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.23B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.35B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.23B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.82B	USD	Point-in-time
Cash and cash equivalents and restricted cash and cash equivalents, at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$3.66B	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$3.15B	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$7.43B	USD	Annual
Interest paid	`InterestPaidNet`	$1.59B	USD	Annual
Interest paid	`InterestPaidNet`	$1.47B	USD	Annual
Interest paid	`InterestPaidNet`	$1.64B	USD	Annual
Interest rate hedges	`InterestReceivedInterestRateHedges`	$42.00M	USD	Annual
Interest rate hedges	`InterestReceivedInterestRateHedges`	$2.00M	USD	Annual
Interest rate hedges	`InterestReceivedInterestRateHedges`	$20.00M	USD	Annual
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.94B	USD	Annual
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$410.00M	USD	Annual
Right-of-use assets obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$314.00M	USD	Annual

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.53	USD	Annual
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.57	USD	Annual
Cash dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.46	USD	Annual
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.76B	USD	Point-in-time
Net income	`ProfitLoss`	$9.20B	USD	Annual
Net income	`ProfitLoss`	$22.02B	USD	Annual
Net income	`ProfitLoss`	$16.06B	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-130.00M	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$471.00M	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-589.00M	USD	Annual
Common stock	`DividendsCommonStockCash`	$8.82B	USD	Annual
Common stock	`DividendsCommonStockCash`	$8.17B	USD	Annual
Common stock	`DividendsCommonStockCash`	$8.57B	USD	Annual
Preferred stock	`DividendsPreferredStockCash`	$1.00M	USD	Annual
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$6.00M	USD	Annual
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$8.00M	USD	Annual
Noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$91.00M	USD	Annual
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$894.00M	USD	Annual
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.47B	USD	Annual
Share-based payment transactions	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.04B	USD	Annual
Purchases of common stock (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	Annual
Purchases of common stock (in shares)	`TreasuryStockSharesAcquired`	213.00M	shares	Annual
Purchases of common stock (in shares)	`TreasuryStockSharesAcquired`	0.00	shares	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	-	USD	Annual
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$8.87B	USD	Annual
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	$1.00M	USD	Annual
Preferred stock conversions and redemptions	`StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock`	$4.00M	USD	Annual
Distribution of Upjohn business	`StockholdersEquityNoteSpinoffTransaction`	$-2.02B	USD	Annual
Other	`StockholdersEquityOther`	$81.00M	USD	Annual
Other	`StockholdersEquityOther`	$92.00M	USD	Annual
Other	`StockholdersEquityOther`	$1.00M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.47B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.45B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$77.46B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$63.76B	USD	Point-in-time

Comprehensive Income 63 line items

Line Item	Tag	Value	Unit	Period
Net income before allocation to noncontrolling interests	`ProfitLoss`	$16.06B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$22.02B	USD	Annual
Net income before allocation to noncontrolling interests	`ProfitLoss`	$9.20B	USD	Annual
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-682.00M	USD	Annual
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$675.00M	USD	Annual
Foreign currency translation adjustments, net	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$772.00M	USD	Annual
Reclassification adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	-	USD	Annual
Reclassification adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	$17.00M	USD	Annual
Reclassification adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	$288.00M	USD	Annual
Other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, total	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$755.00M	USD	Annual
Other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, total	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$387.00M	USD	Annual
Other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, total	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-682.00M	USD	Annual
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$526.00M	USD	Annual
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$476.00M	USD	Annual
Unrealized holding gains/(losses) on derivative financial instruments, net	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax`	$-582.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-21.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$-134.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax`	$664.00M	USD	Annual
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-188.00M	USD	Annual
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-561.00M	USD	Annual
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$660.00M	USD	Annual
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-355.00M	USD	Annual
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$361.00M	USD	Annual
Unrealized holding gains/(losses) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$30.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$188.00M	USD	Annual
Reclassification adjustments for (gains)/losses included in net income	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$-39.00M	USD	Annual
Other comprehensive income (loss), available-for-sale securities adjustment, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$38.00M	USD	Annual
Other comprehensive income (loss), available-for-sale securities adjustment, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$173.00M	USD	Annual
Other comprehensive income (loss), available-for-sale securities adjustment, before tax, total	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-384.00M	USD	Annual
Benefit plans: prior service (costs)/credits and other, net	`OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax`	$-116.00M	USD	Annual
Benefit plans: prior service (costs)/credits and other, net	`OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax`	$7.00M	USD	Annual
Benefit plans: prior service (costs)/credits and other, net	`OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax`	$-52.00M	USD	Annual
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-176.00M	USD	Annual
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-181.00M	USD	Annual
Reclassification adjustments related to amortization of prior service costs and other, net	`OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax`	$-154.00M	USD	Annual
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	-	USD	Annual
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-2.00M	USD	Annual
Reclassification adjustments related to curtailments of prior service costs and other, net	`OtherComprehensiveIncomeLossCurtailmentAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetPriorServiceCostCreditbeforeTax`	$-74.00M	USD	Annual
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$2.00M	USD	Annual
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	$-1.00M	USD	Annual
Other	`OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax`	-	USD	Annual
Other comprehensive income (loss), benefit plans, prior service (costs)/credits, before tax, total	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$189.00M	USD	Annual
Other comprehensive income (loss), benefit plans, prior service (costs)/credits, before tax, total	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$113.00M	USD	Annual
Other comprehensive income (loss), benefit plans, prior service (costs)/credits, before tax, total	`DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax`	$124.00M	USD	Annual
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$-519.00M	USD	Annual
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$243.00M	USD	Annual
Other comprehensive income/(loss), before tax	`OtherComprehensiveIncomeLossBeforeTax`	$48.00M	USD	Annual
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$71.00M	USD	Annual
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$-227.00M	USD	Annual
Tax provision/(benefit) on other comprehensive income/(loss)	`OtherComprehensiveIncomeLossTax`	$178.00M	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-130.00M	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$471.00M	USD	Annual
Other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-589.00M	USD	Annual
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$9.67B	USD	Annual
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$15.93B	USD	Annual
Comprehensive income/(loss) before allocation to noncontrolling interests	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$21.43B	USD	Annual
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$27.00M	USD	Annual
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$43.00M	USD	Annual
Less: Comprehensive income/(loss) attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$18.00M	USD	Annual
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$9.64B	USD	Annual
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$15.91B	USD	Annual
Comprehensive income/(loss) attributable to Pfizer Inc.	`ComprehensiveIncomeNetOfTax`	$21.39B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.